Synonyms: AZD-4721 | AZD4721 | compound 4 [WO2019055509A1] | RIST4721
Compound class:
Synthetic organic
Comment: Vimnerixin (AZD4721/RIST4721 ) is an orally bioavailable CXC chemokine receptor type 2 antagonist [1]. It has minimal activity on CXCR1, so has little effect on neutrophil activation.
|
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
N-[6-[(2R,3S)-3,4-dihydroxybutan-2-yl]oxy-2-[(4-fluorophenyl)methylsulfanyl]pyrimidin-4-yl]-3-methylazetidine-1-sulfonamide |
International Nonproprietary Names | |
INN number | INN |
12281 | vimnerixin |
Synonyms |
AZD-4721 | AZD4721 | compound 4 [WO2019055509A1] | RIST4721 |
Database Links | |
CAS Registry No. | 1418112-77-2 (source: WHO INN record) |
GtoPdb PubChem SID | 472319222 |
PubChem CID | 71209600 |
Search Google for chemical match using the InChIKey | UCCNQCNIPRKLRP-CJNGLKHVSA-N |
Search Google for chemicals with the same backbone | UCCNQCNIPRKLRP |
Search PubMed clinical trials | vimnerixin |
Search PubMed titles | vimnerixin |
Search PubMed titles/abstracts | vimnerixin |
UniChem Compound Search for chemical match using the InChIKey | UCCNQCNIPRKLRP-CJNGLKHVSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | UCCNQCNIPRKLRP-CJNGLKHVSA-N |